By Matt D’Ambrosio, SVP, Chief Compliance and Ethics Officer Sunovion Pharmaceuticals, Darrell Coleman, VP, Chief Compliance Officer Dyncorp International, Christopher Santomassimo, Chief Compliance Officer (North America) Agfa Corp. 2019-01-15T14:24:31.267+00:00
2020-01-24T10:55:00ZProvided by Compliance.ai
Learn how financial compliance, risk, and crime professionals can efficiently track and monitor the growing number of enforcement actions and current trends in Compliance.ai’s latest eBook.
New internal guidance from the U.K. Serious Fraud Office outlines what the regulator considers in determining if a company’s compliance procedures are adequate enough to defend against U.K. Bribery Act charges or qualify for a deferred prosecution agreement.